273 related articles for article (PubMed ID: 29481945)
1. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
[TBL] [Abstract][Full Text] [Related]
2. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
[TBL] [Abstract][Full Text] [Related]
3. Melt-electrospinning as a method to improve the dissolution and physical stability of a poorly water-soluble drug.
Semjonov K; Lust A; Kogermann K; Laidmäe I; Maunu SL; Hirvonen SP; Yliruusi J; Nurk G; Lust E; Heinämäki J
Eur J Pharm Sci; 2018 Aug; 121():260-268. PubMed ID: 29883725
[TBL] [Abstract][Full Text] [Related]
4. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
5. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
[TBL] [Abstract][Full Text] [Related]
6. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
7. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
8. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
9. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
10. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
11. Improvement in the water solubility of drugs with a solid dispersion system by spray drying and hot-melt extrusion with using the amphiphilic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and d-mannitol.
Ogawa N; Hiramatsu T; Suzuki R; Okamoto R; Shibagaki K; Fujita K; Takahashi C; Kawashima Y; Yamamoto H
Eur J Pharm Sci; 2018 Jan; 111():205-214. PubMed ID: 28893625
[TBL] [Abstract][Full Text] [Related]
12. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
13. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
14. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
[TBL] [Abstract][Full Text] [Related]
15. Investigation of drug-polymer miscibility, biorelevant dissolution, and bioavailability improvement of Dolutegravir-polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer solid dispersions.
Lakshman D; Chegireddy M; Hanegave GK; Sree KN; Kumar N; Lewis SA; Dengale SJ
Eur J Pharm Sci; 2020 Jan; 142():105137. PubMed ID: 31706016
[TBL] [Abstract][Full Text] [Related]
16. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
17. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
[TBL] [Abstract][Full Text] [Related]
18. One-step continuous extrusion process for the manufacturing of solid dispersions.
Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
[TBL] [Abstract][Full Text] [Related]
19. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
20. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
